SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-21-040772
Filing Date
2021-02-12
Accepted
2021-02-12 12:08:58
Documents
3
Group Members
COLUMBIA ACORN FUNDCOLUMBIA MANAGEMENT INVESTMENT ADVISERS, LLCCOLUMBIA WANGER ASSET MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d14985dsc13ga.htm SC 13G/A 80964
2 EX-99.I d14985dex99i.htm EX-99.I 1395
3 EX-99.II d14985dex99ii.htm EX-99.II 5563
  Complete submission text file 0001193125-21-040772.txt   89966
Mailing Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474
Business Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474 612-671-8001
AMERIPRISE FINANCIAL INC (Filed by) CIK: 0000820027 (see all company filings)

IRS No.: 133180631 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Subject) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90491 | Film No.: 21624681
SIC: 2834 Pharmaceutical Preparations